Psychedelic highlights | March 29 – 01

Shares :

Psychedelic highlights | March 29 – 01

Here is a summary of the news from the last week in the psychedelics market. The value of the psychedelics market is more than $100 billion according to Cannacord most recent report.

Psychedelic market value by company

Last week performance

Revive TherapeuticsRVV$0.485– 6.7 %
Cybin Inc. CYBN$1.44– 10 %
Field TripFTRP$6.24– 11 %
M2Bio SciencesWUHN$0.77– 12.9 %
MindMedMMED$3.59– 14.7 %
CompassCMPS$37.50– 16.8 %
Mind CureMCUR$0.42– 20.7 %
Psyched WellnessPSYC$0.32– 23.8 %
NuminusNUMI$1.06– 28.8 %
Red Light HollandsTRIP$0.32– 28.8 %

Story of the week

1. MindMed Announces the Addition of Stanford University Neuroscientist as Chair of the Scientific Advisory Board and Announces 2020 Year-End Financial Results [news release]

MindMed Inc. announce the addition of Dr. Robert C. Malenka, an accomplished neuroscientist and psychiatry professor from Stanford University, to Chair the Company’s Scientific Advisory Board. 

And more, MindMed Inc. announce has announced its annual 2020 financial results for the year ended December 31, 2020.  

Read the full news HERE

2. Nova Mentis Announces Promising Research Results and Establishes Serotonin Research Centre [news release]

Nova Mentis Life Science Corp. announce, it has found early indications of a rescue effect with the use of psilocybin on anxiety-like behaviours related to autism spectrum disorder (ASD).

And more, Nova Mentis announce that it is establishing a serotonin research centre in partnership with FourthWall Testing, in Winter Garden, Florida.

Read the full news HERE

3. Core One Labs Completes Acquisition of Ketamine Infusions Centers of Texas Representing the Company’s First Psychedelics Clinic in the U.S. and Announces Fast Entry Inclusion in the Horizons Psychedelic ETF [news release]

Core One Labs  announce it has completed the acquisition (the “Transaction“) of Ketamine Infusions Centers of Texas Inc. (“KICT”), a U.S.-based health and wellness clinic that provides ketamine infusion therapy. 

Read the full news HERE

4. Lobe Sciences Becomes Enterprise Member of NFL Alumni Association [news release]

Lobe Sciences  announce it has become an official Enterprise Member of the NFL Alumni Association.

Read the full news HERE

5. MINDCURE Files Provisional Patent Application For iSTRYM, its Proprietary AI Digital Therapeutics (DTx) SaaS Platform, Designed To Enhance Effectiveness Of Psychedelic-Assisted Therapies For Practitioners And Patients [news release]

Mind Cure announce that it has submitted a provisional patent application with the United States Patent and Trademark Office to cover iSTRYM, the company’s proprietary digital therapeutics (DTx) tool. 

Read the full news HERE

6. Psyched Wellness Initiates Study on AME-1 Extract for Gut Health [news release]

Psyched Wellness announce the company has signed an additional agreement with its CRO partner, KGK Science to further study the anti-inflammatory nature of AME-1. 

Read the full news HERE

7. Tryp Therapeutics Appoints Greg McKee as Chief Executive Officer [news release]

Tryp Therapeutics announce that it has appointed Greg McKee as its Chief Executive Officer. Mr. McKee will also continue in his responsibilities as Chairman of the Board of Directors of the Company..

Read the full news HERE

Sign up for MORE news updates !

This article is written and published by The Cannabis Stock

Disclaimer : The Cannabis Stock wants to promote the cannabis market with the best articles and news on the market. The Cannabis Stock does not recommend selling or buying any of the company mentioned and is not responsible for any losses that may result. The Cannabis Stock are engaged in the business of marketing and advertising companies

The Cannabis Stock and its employees may from time to time own shares of the companies named in the articles. All the facts reported by the cannabis stock are information that comes directly from the companies, from their website or on Sedar and are only published as information.

Click on a star to rate this article !

Average rating 0 / 5. Vote count: 0

No votes so far! Be the first to rate this post.

Shares :